Literature DB >> 9690675

Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease.

J G Sheng1, X Q Zhou, R E Mrak, W S Griffin.   

Abstract

Neuronal injury associated with amyloid plaque progression in Alzheimer disease was examined using TUNEL combined with beta-amyloid immunolabeling. There was a progressive increase in the frequency of TUNEL-positive neurons associated with plaque types representing a hypothesized sequence of plaque evolution, from 20% of neurons not associated with plaques to 40%, 70-80%, and 100% of neurons in diffuse, neuritic, and dense-core non-neuritic plaques, respectively. The total number of neurons associated with end-stage, dense-core, non-neuritic plaques declined by 70% (per unit plaque area) compared with neuritic plaque forms. This decline, together with the fact that virtually all of those remaining were TUNEL-positive, suggests that neuronal cell damage increases as plaques evolve from diffuse to more complex forms and that eventually all plaque-associated neurons are lost. This novel demonstration of neurotoxicity associated with amyloid plaque formation and progression suggests that plaque-associated neuronal injury is a major cause of neuronal loss in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690675      PMCID: PMC3833627          DOI: 10.1097/00005072-199807000-00008

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  15 in total

1.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

2.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

3.  In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression.

Authors:  J C Troncoso; R R Sukhov; C H Kawas; V E Koliatsos
Journal:  J Neuropathol Exp Neurol       Date:  1996-11       Impact factor: 3.685

4.  Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.

Authors:  J G Sheng; R E Mrak; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1998-04       Impact factor: 3.685

5.  DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay.

Authors:  A J Anderson; J H Su; C W Cotman
Journal:  J Neurosci       Date:  1996-03-01       Impact factor: 6.167

6.  A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition.

Authors:  J M Rozemuller; P Eikelenboom; F C Stam; K Beyreuther; C L Masters
Journal:  J Neuropathol Exp Neurol       Date:  1989-11       Impact factor: 3.685

Review 7.  Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.

Authors:  W S Griffin; J G Sheng; M C Royston; S M Gentleman; J E McKenzie; D I Graham; G W Roberts; R E Mrak
Journal:  Brain Pathol       Date:  1998-01       Impact factor: 6.508

8.  Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

Authors:  W S Griffin; J G Sheng; G W Roberts; R E Mrak
Journal:  J Neuropathol Exp Neurol       Date:  1995-03       Impact factor: 3.685

9.  Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ.

Authors:  H Lassmann; C Bancher; H Breitschopf; J Wegiel; M Bobinski; K Jellinger; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients.

Authors:  E Mullaart; M E Boerrigter; R Ravid; D F Swaab; J Vijg
Journal:  Neurobiol Aging       Date:  1990 May-Jun       Impact factor: 4.673

View more
  21 in total

1.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.

Authors:  W S Griffin; J A Nicoll; L M Grimaldi; J G Sheng; R E Mrak
Journal:  Exp Gerontol       Date:  2000-07       Impact factor: 4.032

Review 3.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

4.  Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies.

Authors:  Steven W Barger; Kevin Mark DeWall; Ling Liu; Robert E Mrak; W Sue T Griffin
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

5.  Neuronal and axonal loss are selectively linked to fibrillar amyloid-{beta} within plaques of the aged primate cerebral cortex.

Authors:  Palak Shah; Neeta Lal; Elaine Leung; David E Traul; Alicia Gonzalo-Ruiz; Changiz Geula
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 6.  Interleukin-1 and the immunogenetics of Alzheimer disease.

Authors:  R E Mrak; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  2000-06       Impact factor: 3.685

Review 7.  Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.

Authors:  W Sue T Griffin; Robert E Mrak
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

8.  Beta-amyloid1-42 gene transfer model exhibits intraneuronal amyloid, gliosis, tau phosphorylation, and neuronal loss.

Authors:  G William Rebeck; Hyang-Sook Hoe; Charbel E-H Moussa
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

Review 9.  Neuropathology for the neuroradiologist: plaques and tangles.

Authors:  F J Wippold; N Cairns; K Vo; D M Holtzman; J C Morris
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

10.  Neuroprotective Effects of Electroacupuncture Preventive Treatment in Senescence-Accelerated Mouse Prone 8 Mice.

Authors:  Xiao-Li He; Shi-Hui Zhao; Wei You; Yu-Ying Cai; Yan-Yun Wang; Yong-Ming Ye; Bao-Hui Jia
Journal:  Chin J Integr Med       Date:  2016-09-26       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.